A Study of Islatravir (MK-8591) in Trans and Gender Diverse Participants (MK-8591-035)

Clinical trial NCT05130086 · WITHDRAWN

Trial details

NCT number: NCT05130086
Sponsor: Merck Sharp & Dohme LLC
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Human Immunodeficiency Virus (HIV) Infections

Start date: 2022-10-17
Primary completion: 2024-03-25
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.